Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis

NCT06699394 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

AL Amyloidosis

Interventions

DRUG: Teclistamab (Tec)

Sponsor

Peking University People's Hospital